Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test

As new tests and technologies advance our understanding and diagnostic capabilities of the severe acute respiratory syndrome coronavirus 2 and the coronavirus disease 2019, they must be appropriately validated to make sure test performance is following manufacturer claims. In this study, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuping, Nielsen, Marisa C., Muruato, Antonio E., Fontes-Garfias, Camila R., Ren, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562965/
https://www.ncbi.nlm.nih.gov/pubmed/33130510
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562965/
https://www.ncbi.nlm.nih.gov/pubmed/33130510
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115248

Ejemplares similares